{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:46:08Z","timestamp":1781174768174,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40360-018-0269-3","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:34:48Z","timestamp":1542695688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: a case report and review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-2465","authenticated-orcid":false,"given":"Patricia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Ranches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"issue":"4","key":"269_CR1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/j.1875-9114.1995.tb04378.x","volume":"15","author":"H Jick","year":"1995","unstructured":"Jick H, Derby LE. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity. Pharmacotherapy. 1995;15(4):428\u201332.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"269_CR2","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/clinids\/14.5.1034","volume":"14","author":"JW Kelly","year":"1992","unstructured":"Kelly JW, Dooley DP, Lattuada CP, Smith CE. A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992;14(5):1034\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"269_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/clinids\/23.6.1313","volume":"23","author":"E Caumes","year":"1996","unstructured":"Caumes E, Guermonprez G, Winter C, Katlama C, Bricaire F. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus. Clin Infect Dis. 1996;23(6):1313\u20134.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"269_CR4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/j.1875-9114.1990.tb03574.x","volume":"10","author":"MP Johnson","year":"1990","unstructured":"Johnson MP, Goodwin SD, Shands JW Jr. Trimethoprim-sulfamethoxazole anaphylactoid reactions in patients with AIDS: case reports and literature review. Pharmacotherapy. 1990;10(6):413\u20136.","journal-title":"Pharmacotherapy"},{"key":"269_CR5","doi-asserted-by":"crossref","unstructured":"Farrukh Abbas MP, Abbas K, Shah P, Gurel M. Trimethoprim-sulfamethoxazole (TMP-SMX) induced severe systemic reaction. J Pulm Respir Med. 2017;7(1).","DOI":"10.4172\/2161-105X.1000393"},{"issue":"23","key":"269_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","volume":"328","author":"SA Coopman","year":"1993","unstructured":"Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328(23):1670\u20134.","journal-title":"N Engl J Med"},{"issue":"21","key":"269_CR7","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/archinte.1994.00420210028004","volume":"154","author":"AC Jung","year":"1994","unstructured":"Jung AC, Paauw DS. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Arch Intern Med. 1994;154(21):2402\u20136.","journal-title":"Arch Intern Med"},{"issue":"5","key":"269_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","volume":"100","author":"JA Kovacs","year":"1984","unstructured":"Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100(5):663\u201371.","journal-title":"Ann Intern Med"},{"issue":"12","key":"269_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJM199009203231202","volume":"323","author":"I Medina","year":"1990","unstructured":"Medina I, Mills J, Leoung G, et al. Oral therapy for pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med. 1990;323(12):776\u201382.","journal-title":"N Engl J Med"},{"issue":"2","key":"269_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199502000-00004","volume":"8","author":"MJ Rieder","year":"1995","unstructured":"Rieder MJ, Krause R, Bird IA, Dekaban GA. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(2):134-140.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"10","key":"269_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/003655401317074581","volume":"33","author":"C Rabaud","year":"2001","unstructured":"Rabaud C, Charreau I, Izard S, et al. Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression. Scand J Infect Dis. 2001;33(10):759\u201364.","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"269_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/clinids\/17.5.885","volume":"17","author":"BY Nguyen","year":"1993","unstructured":"Nguyen BY, Landucci DL, Cunnion RE, Yarchoan R, Walker RE. A case of hyperdynamic shock caused by trimethoprim-sulfamethoxazole in which no tumor necrosis factor or features of anaphylaxis were detected. Clin Infect Dis. 1993;17(5):885\u20137.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"269_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1258\/ijsa.2010.010079","volume":"21","author":"A Scourfield","year":"2010","unstructured":"Scourfield A, Tan LK, Nelson M. Severe septic-shock like reaction to co-trimoxazole in an HIV-positive man. Int J STD AIDS. 2010;21(7):521\u20133.","journal-title":"Int J STD AIDS"},{"issue":"7","key":"269_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/0956462415587442","volume":"27","author":"J Persichino","year":"2016","unstructured":"Persichino J, Sutjita M. Anaphylactic-like reaction from trimethoprim-sulfamethoxazole in a patient with AIDS. Int J STD AIDS. 2016;27(7):595\u20137.","journal-title":"Int J STD AIDS"},{"issue":"13","key":"269_CR15","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.160.13.2066","volume":"160","author":"J Antonen","year":"2000","unstructured":"Antonen J, Hulkkonen J, Pasternack A, Hurme M. Interleukin 6 may be an important mediator of trimethoprim-induced systemic adverse reaction resembling aseptic meningitis. Arch Intern Med. 2000;160(13):2066\u20137.","journal-title":"Arch Intern Med"},{"issue":"12","key":"269_CR16","first-page":"2585","volume":"26","author":"J Antonen","year":"1999","unstructured":"Antonen J, Saha H, Hulkkonen J, Lumio J, Pasternack A, Hurme M. Increased in vitro production of interleukin 6 in response to trimethoprim among persons with trimethoprim induced systemic adverse reactions. J Rheumatol. 1999;26(12):2585\u201390.","journal-title":"J Rheumatol"},{"issue":"3","key":"269_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.medmal.2013.02.009","volume":"43","author":"M Vernier","year":"2013","unstructured":"Vernier M, Million M, Laugier D, Le Treut T, Brouqui P, Botelho-Nevers E. Macrophage activation syndrome associated with co-trimoxazole. Med Mal Infect. 2013;43(3):128\u201330.","journal-title":"Med Mal Infect"},{"issue":"1","key":"269_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0002-9343(91)90069-A","volume":"91","author":"T Calandra","year":"1991","unstructured":"Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 immunoglobulin study group. Am J Med. 1991;91(1):23\u20139.","journal-title":"Am J Med"},{"issue":"3","key":"269_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/clinids\/19.3.431","volume":"19","author":"MS Harrison","year":"1994","unstructured":"Harrison MS, Simonte SJ, Kauffman CA. Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. Clin Infect Dis. 1994;19(3):431\u20134.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"269_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.7326\/0003-4819-119-4-199308150-00007","volume":"119","author":"S Greenberg","year":"1993","unstructured":"Greenberg S, Reiser IW, Chou SY, Porush JG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med. 1993;119(4):291\u20135.","journal-title":"Ann Intern Med"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-018-0269-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0269-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:09:48Z","timestamp":1775275788000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-018-0269-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1186\/s40360-018-0269-3","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"5 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written and verbal consent from the patient has been obtained. As stated in the instructions, a consent form has not been included on submission but is available for request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"76"}}